logo

8.7

8.70 (-0.02%)

As of Jun 14, 2022

Impel Pharmaceuticals Inc [IMPL]

Source: 

Company Overview

We are a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the Central Nervous System, or CNS. Our company was founded on the premise that the upper nasal space can be an optimal treatment entry point for CNS and other diseases where rapid vascular absorption can result in superior clinical outcomes.

CountryUnited States
Headquartersseattlewashington
Phone Number206-568-1466
Industry
manufacturing
CEOAdrian Adams
Website